MLM
GILD icon

Mount Lucas Management’s Gilead Sciences GILD Stock Holding History

Mount Lucas Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,089
Closed -$212K – 150
2024
Q2 		$212K Buy
+3,089
New +$206K 0.06% 144

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mount Lucas Management's GILD Position: Q3 2024 in Review

Mount Lucas Management sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 3,089 shares — an estimated $212K sold.

Mount Lucas Management first reported a position in GILD in Q2 2024 and held it in 1 quarter. The position peaked at $212K in Q2 2024. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Mount Lucas Management reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Mount Lucas Management sold 3,089 Gilead Sciences shares in Q3 2024, an estimated $212K.
  • Mount Lucas Management first reported a position in Gilead Sciences in Q2 2024 and held it in 1 quarter.
  • Mount Lucas Management's Gilead Sciences position peaked at $212K in Q2 2024.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Mount Lucas Management's 13F filing for Q3 2024, filed 6 Nov 2024.